Daxor Operating Income 2010-2011 | DXR

Daxor operating income from 2010 to 2011. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Daxor Annual Operating Income
(Millions of US $)
2011 $-6
2010 $-6
2009 $-5
Daxor Quarterly Operating Income
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-1
2011-06-30 $-1
2011-03-31 $-2
2010-12-31 $-2
2010-09-30 $-1
2010-06-30 $-2
2010-03-31 $-1
2009-12-31 $-1
2009-09-30 $-1
2009-06-30 $-1
2009-03-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.045B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.765B 18.49
Encompass Health (EHC) United States $11.937B 25.31
DaVita (DVA) United States $10.763B 15.13
Elanco Animal Health (ELAN) United States $7.400B 15.85
Chemed (CHE) United States $6.728B 21.15
Option Care Health (OPCH) United States $4.893B 21.81
RadNet (RDNT) United States $4.163B 264.19
Amedisys (AMED) United States $3.189B 21.45
Addus HomeCare (ADUS) United States $2.041B 22.41
LifeStance Health (LFST) United States $1.754B 0.00
Astrana Health (ASTH) United States $1.396B 34.58
U.S Physical Therapy (USPH) United States $1.132B 29.22
Pennant (PNTG) United States $0.870B 31.94
Aveanna Healthcare Holdings (AVAH) United States $0.792B 45.11
Atai Life Sciences (ATAI) Germany $0.525B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00